Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Stylized skeletal formula (chemical structure). Atoms are shown as color-coded circles with thick black outlines and bonds: hydrogen (hidden), carbon (grey), oxygen (red), nitrogen (blue), fluorine (green). | |
Licence : | Libre de droits |
Crédit: | Science Photo Library / Molekuul |
Model Release : | Non requis |
Property Release : | Non requis |
Restrictions : | - |